{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:57Z","timestamp":1787181897946,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011773","name":"R\u00e9gion Franche-Comt\u00e9","doi-asserted-by":"publisher","award":["2021-Y-08292"],"award-info":[{"award-number":["2021-Y-08292"]}],"id":[{"id":"10.13039\/501100011773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011773","name":"R\u00e9gion Franche-Comt\u00e9","doi-asserted-by":"publisher","award":["2021-Y-08290"],"award-info":[{"award-number":["2021-Y-08290"]}],"id":[{"id":"10.13039\/501100011773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015390","name":"Universit\u00e9 de Franche-Comt\u00e9","doi-asserted-by":"publisher","award":["CR3300"],"award-info":[{"award-number":["CR3300"]}],"id":[{"id":"10.13039\/501100015390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003134","name":"Fonds pour la Formation \u00e0 la Recherche dans l\u2019Industrie et dans l\u2019Agriculture","doi-asserted-by":"publisher","award":["grant n\\u00B035484055"],"award-info":[{"award-number":["grant n\\u00B035484055"]}],"id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010527","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["PER (40003433, VIRUSURF)"],"award-info":[{"award-number":["PER (40003433, VIRUSURF)"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["PDR grant T.0292.24"],"award-info":[{"award-number":["PDR grant T.0292.24"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018003","name":"Les Amis des Instituts Pasteur \u00e0 Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119753","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:25:48Z","timestamp":1785875148000},"page":"119753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Highly potent antiviral drug candidates targeting SARS-CoV-2 nsp3 and nsp5"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-4349","authenticated-orcid":false,"given":"Mathilde","family":"Galais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Herlem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Haidar Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Dutilleul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-797X","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Pasquereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-5870","authenticated-orcid":false,"given":"Ranim","family":"El Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bellefroid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8584-1068","authenticated-orcid":false,"given":"Estelle","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2840-6440","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Morot-Bizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Picaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2026.119753_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-803109-4.00017-9","article-title":"Family coronaviridae","author":"Payne","year":"2017","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.biopha.2026.119753_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2026.119753_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51230","article-title":"The human coronavirus HCoV-229E S-protein structure and receptor binding","volume":"8","author":"Li","year":"2019","journal-title":"eLife"},{"issue":"7807","key":"10.1016\/j.biopha.2026.119753_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","article-title":"SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species","volume":"10","author":"Moustaqil","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2026.119753_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of SARS-CoV-2 PLpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2026.119753_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir. Res."},{"issue":"31","key":"10.1016\/j.biopha.2026.119753_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305674120","article-title":"Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib11","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","article-title":"Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2","volume":"14","author":"Sanders","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2026.119753_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011614","article-title":"A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo","volume":"19","author":"Taha","year":"2023","journal-title":"PLOS Pathog."},{"issue":"12","key":"10.1016\/j.biopha.2026.119753_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105346","article-title":"SARS-CoV-2 papain-like protease plays multiple roles in regulating cellular proteins in the endoplasmic reticulum","volume":"299","author":"Yang","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119753_bib14","doi-asserted-by":"crossref","first-page":"e01969-20","DOI":"10.1128\/JVI.01969-20","article-title":"The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase","volume":"95","author":"Alhammad","year":"2021","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.biopha.2026.119753_bib15","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1128\/JVI.02050-13","article-title":"Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity","volume":"87","author":"Stobart","year":"2013","journal-title":"J. Virol."},{"issue":"6497","key":"10.1016\/j.biopha.2026.119753_bib16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119753_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2023.02.011","article-title":"Genetic conservation across SARS-CoV-2 non-structural proteins - insights into possible targets for treatment of future viral outbreaks","volume":"581","author":"Kandwal","year":"2023","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.biopha.2026.119753_bib18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cid\/ciaf111","article-title":"A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: have the Guidelines Evolved With the Evidence?","volume":"81","author":"Bartoletti","year":"2025","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"10","key":"10.1016\/j.biopha.2026.119753_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00697-22","article-title":"A Randomized Phase 2\/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: results of the Phase 2a Part","volume":"66","author":"Mukae","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/v15040976","article-title":"The antiviral effect of nirmatrelvir\/ritonavir during COVID-19 Pandemic Real-World Data","volume":"15","author":"Petrakis","year":"2023","journal-title":"Viruses"},{"issue":"6575","key":"10.1016\/j.biopha.2026.119753_bib22","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119753_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103385","article-title":"An epigenetic signature to fight COVID-19","volume":"67","author":"Herbein","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-020-00912-7","article-title":"Management of epigenomic networks entailed in coronavirus infections and COVID-19","volume":"12","author":"El Baba","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"40","key":"10.1016\/j.biopha.2026.119753_bib25","doi-asserted-by":"crossref","first-page":"41599","DOI":"10.1021\/acsomega.4c05480","article-title":"Inhibition of the SARS-CoV-2 Non-structural Protein 5 (NSP5) protease by nitrosocarbonyl-bases small molecules","volume":"9","author":"Leusciatti","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2026.119753_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118246","article-title":"Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods","volume":"189","author":"Omer","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119753_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108624","article-title":"Tipranavir analogs as antiviral agents: design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors","volume":"163","author":"El-Sayed","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7811","key":"10.1016\/j.biopha.2026.119753_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib29","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119753_bib30","doi-asserted-by":"crossref","first-page":"W345","DOI":"10.1093\/nar\/gkz424","article-title":"PrankWeb: a web server for ligand binding site prediction and visualization","volume":"47","author":"Jendele","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119753_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.accounts.5b00516","article-title":"Protein binding pocket dynamics","volume":"49","author":"Stank","year":"2016","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119753_bib32","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.biopha.2026.119753_bib33","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acs.jcim.6b00740","article-title":"Protein-ligand scoring with convolutional neural networks","volume":"57","author":"Ragoza","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Chemin.-."},{"key":"10.1016\/j.biopha.2026.119753_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.815389","article-title":"SARS-CoV-2 mutations and their impact on diagnostics, therapeutics and vaccines","volume":"9","author":"Thakur","year":"2022","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib37","doi-asserted-by":"crossref","first-page":"msad085","DOI":"10.1093\/molbev\/msad085","article-title":"Evolution of the SARS-CoV-2 mutational spectrum","volume":"40","author":"Bloom","year":"2023","journal-title":"Mol. Biol. Evol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00869-22","article-title":"Genetic Surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor paxlovid","volume":"13","author":"Lee","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2026.119753_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119753_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105344","article-title":"Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening","volume":"203","author":"Roy","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2026.119753_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105084","article-title":"Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulations","volume":"140","author":"Patel","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"28","key":"10.1016\/j.biopha.2026.119753_bib43","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1021\/acs.biochem.0c00309","article-title":"Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3","volume":"59","author":"Frick","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119753_bib44","article-title":"SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice \u00bb","author":"Alhammad","year":"2023","journal-title":"BioRxiv Prepr. Serv. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119753_bib45","first-page":"1162","article-title":"Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3","volume":"25","author":"Virdi","year":"2020","journal-title":"SLAS Discov. Adv. Life Sci. R. D."},{"issue":"10","key":"10.1016\/j.biopha.2026.119753_bib46","first-page":"1221","article-title":"An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors","volume":"12","author":"O\u2019Connor","year":"2023","journal-title":"\u00bb Pathog. Basel Switz."},{"issue":"9","key":"10.1016\/j.biopha.2026.119753_bib47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/v15091907","article-title":"Targeting SARS-CoV-2 Macrodomain-1 to restore the innate immune response using in silico screening of medicinal compounds and free energy calculation approaches","volume":"15","author":"Mohammad","year":"2023","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.biopha.2026.119753_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02404-21","article-title":"New perspectives on antimicrobial agents: molnupiravir and nirmatrelvir\/ritonavir for treatment of COVID-19","volume":"66","author":"Atmar","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.biopha.2026.119753_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.medj.2023.08.001","article-title":"Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2","volume":"4","author":"Hirotsu","year":"2023","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119753_bib50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciad494","article-title":"Nirmatrelvir Resistance\u2014de Novo E166V\/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir\/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure\u2014a Case Report","volume":"78","author":"Zuckerman","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"23","key":"10.1016\/j.biopha.2026.119753_bib51","doi-asserted-by":"crossref","first-page":"eadv8875","DOI":"10.1126\/sciadv.adv8875","article-title":"Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 protease","volume":"11","author":"Neilsen","year":"2025","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.biopha.2026.119753_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acscentsci.3c00054","article-title":"SARS-CoV-2 Mpro protease variants of concern display altered viral substrate and cell host target galectin-8 processing but retain sensitivity toward antivirals","volume":"9","author":"Chen","year":"2023","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119753_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41980","article-title":"SARS-CoV-2 drug resistance and therapeutic approaches","volume":"11","author":"Batool","year":"2025","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2026.119753_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acscentsci.2c01359","article-title":"Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro","volume":"9","author":"Hou","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biopha.2026.119753_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antivir. Res."},{"issue":"Pt 5","key":"10.1016\/j.biopha.2026.119753_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1107\/S2052252520009653","article-title":"Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes","volume":"7","author":"Michalska","year":"2020","journal-title":"IUCrJ"},{"issue":"13","key":"10.1016\/j.biopha.2026.119753_bib57","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/bioinformatics\/btv082","article-title":"Fast, accurate, and reliable molecular docking with QuickVina 2 \u00bb","volume":"31","author":"Alhossary","year":"2015","journal-title":"Bioinforma. Oxf. Engl."},{"issue":"1","key":"10.1016\/j.biopha.2026.119753_bib58","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.1038\/s41598-017-15571-7","article-title":"Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration","volume":"7","author":"Hassan","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2026.119753_bib59","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/B613014N","article-title":"The growing applications of click chemistry","volume":"36","author":"Moses","year":"2007","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2026.119753_bib60","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.jmedchem.5b00886","article-title":"OpenGrowth: An Automated and Rational Algorithm for Finding New Protein Ligands","volume":"59","author":"Ch\u00e9ron","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119753_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.jcim.6b00610","article-title":"A Hybrid Knowledge-Based and Empirical Scoring Function for Protein-Ligand Interaction: SMoG2016","volume":"57","author":"Debroise","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.biopha.2026.119753_bib62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119753_bib63","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119753_bib64","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone \u03d5, \u03c8 and Side-Chain \u03c71 and \u03c72 Dihedral Angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theory Comput."},{"issue":"11","key":"10.1016\/j.biopha.2026.119753_bib65","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119753_bib66","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An Infectious cDNA Clone of SARS-CoV-2","volume":"27","author":"Xie","year":"2020","journal-title":"Cell. Host Microbe"},{"issue":"93","key":"10.1016\/j.biopha.2026.119753_bib67","doi-asserted-by":"crossref","DOI":"10.3791\/52065-v","article-title":"Viral concentration determination through plaque assays: using traditional and novel overlay systems","author":"Baer","year":"2014","journal-title":"J. Vis. Exp."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:51:05Z","timestamp":1787179865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0753332226007894"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119753","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly potent antiviral drug candidates targeting SARS-CoV-2 nsp3 and nsp5","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119753"}}